NO178137C - Fremgangsmåte for fremstilling av et polyprenylholdig farmasöytisk preparat i form av harde kapsler - Google Patents

Fremgangsmåte for fremstilling av et polyprenylholdig farmasöytisk preparat i form av harde kapsler

Info

Publication number
NO178137C
NO178137C NO901209A NO901209A NO178137C NO 178137 C NO178137 C NO 178137C NO 901209 A NO901209 A NO 901209A NO 901209 A NO901209 A NO 901209A NO 178137 C NO178137 C NO 178137C
Authority
NO
Norway
Prior art keywords
polyprenyl
preparation
pharmaceutical composition
hard capsules
containing pharmaceutical
Prior art date
Application number
NO901209A
Other languages
English (en)
Norwegian (no)
Other versions
NO901209D0 (no
NO178137B (no
NO901209L (no
Inventor
Keizo Uesugi
Nobutaka Noda
Michiru Tanaka
Masanori Kayano
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP6538589A external-priority patent/JP2812977B2/ja
Priority claimed from JP1065384A external-priority patent/JP2928261B2/ja
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of NO901209D0 publication Critical patent/NO901209D0/no
Publication of NO901209L publication Critical patent/NO901209L/no
Publication of NO178137B publication Critical patent/NO178137B/no
Publication of NO178137C publication Critical patent/NO178137C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pyrane Compounds (AREA)
NO901209A 1989-03-17 1990-03-15 Fremgangsmåte for fremstilling av et polyprenylholdig farmasöytisk preparat i form av harde kapsler NO178137C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6538589A JP2812977B2 (ja) 1989-03-17 1989-03-17 ポリプレニル系化合物含有硬カプセル剤の製造方法
JP1065384A JP2928261B2 (ja) 1989-03-17 1989-03-17 安定なポリプレニル系化合物含有組成物の製法

Publications (4)

Publication Number Publication Date
NO901209D0 NO901209D0 (no) 1990-03-15
NO901209L NO901209L (no) 1990-09-18
NO178137B NO178137B (no) 1995-10-23
NO178137C true NO178137C (no) 1996-01-31

Family

ID=26406534

Family Applications (1)

Application Number Title Priority Date Filing Date
NO901209A NO178137C (no) 1989-03-17 1990-03-15 Fremgangsmåte for fremstilling av et polyprenylholdig farmasöytisk preparat i form av harde kapsler

Country Status (10)

Country Link
US (1) US5304381A (ko)
EP (1) EP0387655B1 (ko)
KR (1) KR920005812B1 (ko)
AT (1) ATE100709T1 (ko)
DE (1) DE69006236T2 (ko)
DK (1) DK0387655T3 (ko)
ES (1) ES2062133T3 (ko)
FI (1) FI901046A0 (ko)
NO (1) NO178137C (ko)
PH (1) PH26952A (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW523816B (en) 2000-06-16 2003-03-11 Gen Semiconductor Inc Semiconductor trench device with enhanced gate oxide integrity structure
KR20210038414A (ko) * 2018-07-30 2021-04-07 다이이찌 산쿄 가부시키가이샤 안정화제를 함유하는 의약품의 고형 제제

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH433944A (de) * 1962-12-17 1967-04-15 Hoffmann La Roche Präparat zur Vitaminierung von Lebens- und Futtermitteln und Verfahren zu dessen Herstellung
JPS5115094B2 (ko) * 1972-11-01 1976-05-14
JPS5815940A (ja) * 1981-07-23 1983-01-29 Eisai Co Ltd ポリプレニル系化合物およびその製造方法ならびにそれを含有する医薬
JPS5832873A (ja) * 1981-08-20 1983-02-25 Eisai Co Ltd ポリプレニルアミド系化合物含有組成物
DE3201511A1 (de) * 1982-01-20 1983-07-28 Henkel Kgaa Sebosuppressive kosmetische mittel, welche laengerkettige alkanole und antioxidantien enthalten
EP0138216B1 (en) * 1983-10-14 1993-01-07 Sumitomo Pharmaceuticals Company, Limited Sustained-release ifn preparation for parenteral administration
US4711894A (en) * 1986-01-16 1987-12-08 Henkel Corporation Stabilized tocopherol in dry, particulate, free-flowing form
FI96169C (fi) * 1989-07-10 1996-05-27 Eisai Co Ltd Menetelmä polyprenyyliyhdistettä sisältävän farmaseuttisen koostumuksen valmistamiseksi

Also Published As

Publication number Publication date
NO901209D0 (no) 1990-03-15
US5304381A (en) 1994-04-19
EP0387655A3 (en) 1991-06-05
FI901046A0 (fi) 1990-03-01
EP0387655A2 (en) 1990-09-19
EP0387655B1 (en) 1994-01-26
DK0387655T3 (da) 1994-02-28
ES2062133T3 (es) 1994-12-16
KR900013957A (ko) 1990-10-22
PH26952A (en) 1992-12-03
NO178137B (no) 1995-10-23
KR920005812B1 (ko) 1992-07-20
DE69006236D1 (de) 1994-03-10
NO901209L (no) 1990-09-18
DE69006236T2 (de) 1994-07-07
ATE100709T1 (de) 1994-02-15

Similar Documents

Publication Publication Date Title
BR1100445A (pt) Derivados imino cìclicos, composições farmacêuticas contendo estes compostos e processo para sua preparação
DE3775882D1 (de) Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeuren ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen.
BG92179A (bg) Метод за получаване на 7-заместена-хепт-6-еноена и -хептаноена киселина и техни производни и междинни съединения
FI854227L (fi) Menetelmä analgeettisena aineena käyttökelpoisten polypeptidien valmistamiseksi
DK0559079T3 (da) Substituerede aminophosphonatderivater, fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende derivaterne
PT96030A (pt) Processo para a preparacao de aminocarbonilcarbamatos relacionados com fisoestigmina e de composicoes farmaceuticas que os contem
DK183789D0 (da) 2-alkyl-3-benzoylbenzofuraner og laegemidler indeholdende disse
DE69206787D1 (de) 4-[(2-Benzothiazolyl)Methylamino]-alpha-(3,4-Difluorphenoxy)methyl-1-piperidenethanol
NO178137C (no) Fremgangsmåte for fremstilling av et polyprenylholdig farmasöytisk preparat i form av harde kapsler
NO177484C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat i form av myke kapsler
DE3787844D1 (de) Thioester und dessen Verwendung zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Ischämie und von Reperfusion-Syndromen.
ES2182086T3 (es) Nuevos derivados de peptidil-arginina aldehido.
PT90302A (pt) Processo para a preparacao de derivados de lactamas hetero-tetraciclicas
DK0410278T3 (da) Reninhæmmende aminooligohydroxyderivater
ATE43594T1 (de) 3-alkoxy-2-(n-pyrrolidino)-n-pyridyl-n-furyl(od r thienyl)-methyl-propylamine, ihre herstellung und diese enthaltende pharmazeutische mittel.
ATE120731T1 (de) Optisch aktives derivat der d-2-(6-methoxy-2- naphthyl)-propionsäure und es enthaltende pharmazeutische zusammensetzungen.
ES8401966A1 (es) Procedimiento para preparar las (2,3-dihidro(1,4-benzodioxin-2-il) alcoil) piperidin-4-il-(n-ciano-n'-r) guanidinas.
PT90717A (pt) Processo de preparacao de 3,4,5,6-tetra-hidrofuro {4,3,2,ef}{3}benzazepinas substituidas e de composicoes farmaceuticas que as contem
DE69011174D1 (de) Catecholaminester.
FI933928A (fi) Heteroarenylpiperaziner, foerfarande foer framstaellning av dessa och anvaendning som laekemedel